Full length article
Up-regulation of cullin7 promotes proliferation and migration of pulmonary artery smooth muscle cells in hypoxia-induced pulmonary hypertension

https://doi.org/10.1016/j.ejphar.2019.172698Get rights and content

Abstract

It has well been demonstrated that E3 ubiquitin ligase cullin7 plays important roles in cancer cell growth control via down-regulating p53 expression. The noncanonical function or the pathogenic role of p53 has more recently been implicated in pulmonary vascular remodeling. Therefore, whether cullin7 participates in hypoxia-induced pulmonary vascular remodeling deserves to be elucidated. The present study found that hypoxia up-regulated the expression of cullin7 mRNA and protein in pulmonary arteries and pulmonary artery smooth muscle cells, and knockdown of cullin7 inhibited hypoxia-induced proliferation and migration of pulmonary artery smooth muscle cells and reversed hypoxia-induced inhibition of p53 expression. Notably, administration of proteasome inhibitor MG132 significantly inhibited the expression of cullin7 and up-regulated the expression of p53 in pulmonary arteries concomitantly with improvement of hypoxia-induced pulmonary vascular remodeling. Our study demonstrated that hypoxia induced up-regulation of cullin7 expression resulting to the proliferation and migration of pulmonary artery smooth muscle cells via down-regulating p53 expression, which contributed to pulmonary vascular remodeling.

Introduction

Pulmonary hypertension (PH) is an intractable disease characterized by the increase in pulmonary vascular resistance and pulmonary artery pressure (Lai et al., 2014). Increased mitotic fission, phenotypic switch and excessive ability of pulmonary artery smooth muscle cells (PASMCs) to proliferate have been recognized as important contributors to pulmonary vascular remodeling in PH (Lyle et al., 2017). Although the role of PASMCs in the pathogenesis of PH, the underlying molecular mechanisms are still not exactly understood.

The ubiquitin-proteasome pathway degrades 80% proteins. Firstly, the ubiquitin molecule is activated by the E1 activating enzyme, then the E2 conjugated enzyme “holds” the activated ubiquitin molecule, and finally the ubiquitined protein is covalently transferred to one or more lysine residues of the target protein by E3 ubiquitin ligase (Hershko and Ciechanover, 1998). This highly specific intracellular degradation mechanism is mainly determined by E3 ubiquitin ligases, in which cullin-ring ligase (CRL) mainly composed of cullin7 protein regulates approximately 20% of protein ubiquitination degradation (Deshaies and Joazeiro, 2009; Schulman and Harper, 2009). Recent studies have found that E3 ubiquitin ligase cullin7 plays important roles in cancer cell growth control (Chen and Yao, 2016; Guo et al., 2014; Xi et al., 2016; Zhang et al., 2016). Notably, over-expressed cullin7 promotes proliferation and invasion of breast and lung cancer cells by inhibiting p53 expression (Guo et al., 2014; Men et al., 2015). PH pathogenesis has many similarities with carcinogenesis (Courboulin et al., 2016). It has shown that MG132, an inhibitor of ubiquitin proteasome, inhibits proliferation of PASMCs and reduces the pulmonary vascular wall thickness in hypoxia/SU5416-induced PH in rats (Ibrahim et al., 2014; Li et al., 2011). Therefore, whether cullin7 could participate in pulmonary vascular remodeling in hypoxia-induced PH deserves to be elucidated.

The tumor-suppressive role of transcription factor p53 has been linked to cell cycle arrest, apoptosis, and senescence (Wang and Sun, 2010). The noncanonical function or the pathogenic role of p53 has more recently been implicated in pulmonary vascular disease (Jacquin et al., 2015; Mizuno et al., 2011; Mouraret et al., 2013). It has been shown that cullin7 promotes cell growth by binding to p53 to inhibit its function (Andrews et al., 2006). We therefore hypothesized that cullin7 could promote the proliferation and migration of PASMCs by down-regulating p53 expression, which contributes to hypoxia-induced pulmonary vascular remodeling.

This study is designed to explore the role of cullin7 in mediating hypoxia-induced pulmonary vascular remodeling and the underlying mechanisms. Our results demonstrated that hypoxia induced up-regulation of cullin7 expression resulting to the proliferation and migration of PASMCs by inhibiting p53 expression, which contributed to pulmonary vascular remodeling.

Section snippets

Animal experiments

Male Sprague-Dawley rats (180–220 g) were obtained from the Laboratory Animal Center, Xiang-Ya School of Medicine, Central South University, Changsha, China (SCXX (XIANG) 2009–0004). All animals received humane care in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (National Institutes of Health, 2011). The protocols on the ethics of animal (No. CSU2017009) were approved by the Medicine Animal Welfare Committee of Xiangya School of Medicine,

Cullin7 was up-regulated in hypoxia-exposed pulmonary arteries and PASMCs

Hypoxia has been considered as an important pathogenic factor to promote PASMCs proliferation resulting to pulmonary vascular remodeling (Lyle et al., 2017). In keeping with our previous study (Zhang et al., 2017b, Zhang et al., 2017a), hypoxia resulted in less weight-gain (Fig. S1A) and induced PH in rats, as shown by significant increases in RVSP (Fig. S1B), right ventricle hypertrophy as determined by a higher ratio of RV weight to tibial length (Fig. S1C) and by a higher ratio of RV weight

Discussion

The present study demonstrated that hypoxia up-regulated cullin7 expression resulting to the proliferation and migration of PASMCs via down-regulating p53 expression, which contributed to pulmonary vascular remodeling.

Timely intracellular protein degradation regulates a broad spectrum of fundamental cellular functions, including cell proliferation and phenotypic transition (Scheufele et al., 2014). It has well been demonstrated that E3 ubiquitin ligase cullin7 promotes the ability of cancer

Declaration of competing interest

The authors declare that there are no conflicts of interest.

Acknowledgments

This work was supported by grants from the National Natural Science Foundation of China (No. 91439105, 81473209, 81872872) and the Open Sharing Fund for the Large-scale Instruments and Equipments of Central South University (CSUZC201935).

References (32)

  • O. Boucherat et al.

    The cancer theory of pulmonary arterial hypertension

    Pulm. Circ.

    (2017)
  • P. Chen et al.

    The role of cullin proteins in gastric cancer

    Tumor Biol.

    (2016)
  • A. Courboulin et al.

    MicroRNA networks in pulmonary arterial hypertension: share mechanisms with cancer?

    Curr. Opin. Oncol.

    (2016)
  • R.J. Deshaies et al.

    RING domain E3 ubiquitin ligases

    Annu. Rev. Biochem.

    (2009)
  • A. Hershko et al.

    The ubiquitin system

    Annu. Rev. Biochem.

    (1998)
  • Y.F. Ibrahim et al.

    Mechanism of the susceptibility of remodeled pulmonary vessels to drug-induced cell killing

    J. Am. Heart Assoc.

    (2014)
  • Cited by (5)

    • The p53 pathway in vasculature revisited: A therapeutic target for pathological vascular remodeling?

      2021, Pharmacological Research
      Citation Excerpt :

      This type of lesion has also been recognized to have a determinant role in causing pulmonary hypertension [83,84]. Emerging evidence from both animal and human studies supports that the level of p53 protein is decreased in the lungs with PAH [85–88]. More specifically, in murine and rat models of PAH, p53 expression is downregulated in PASMCs, but is upregulated in PAECs [89].

    View full text